Table 3

Future intention to test for prostate cancer comparing jury to controls

Predicting future intention to test for prostate cancer*
BSE BCI lowerCI upperp Value
Constant−0.111.51−3.253.030.944
Preassessment intention to test score0.720.160.381.060.000
How many times tested previously0.660.190.261.060.003
Group membership (jury/control)−4.311.09−6.58−2.040.001
  • Note. N=25.

  • *As it was anticipated that men who had been tested for prostate cancer previously would be more likely to continue with this course of action, group differences in intention to be tested for prostate cancer in the future were examined using linear regression, adjusting for baseline future intention to test, the number of times a man had a prostate-specific antigen test at baseline, and his group membership.